February 2026 Outlook

Showing 1502 articles
Business

Gold and Silver Extend Slide as Fed Speculation Rattles Markets

Precious metals extended losses in Asian trading Monday, following a sharp sell-off triggered by speculation over a more hawkish Federal Reserve leadership. Despite the pullback, both gold and silver remain significantly higher for the year, supported by enduring central bank demand and geopolitical uncertainty.

Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.